John F. Walsh, Group Chief Exec-Com, Med & Technology at Accenture plc (ACN), sold 11,834 shares at $209.14 ($2.5M) on 2020-01-21, disclosed to the SEC on 2020-01-23.
Open-market sale of $2.5M ACN by Group Chief Exec-Com, Med & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $208.32 | 166 | $35K | 1.4% |
| 2 | $209.14 | 4,971 | $1.0M | 42.0% |
| 3 | $209.14 | 4,971 | $1.0M | 42.0% |
| 4 | $209.78 | 863 | $181K | 7.3% |
| 5 | $209.78 | 863 | $181K | 7.3% |
| Total | $209.22 avg | 11,834 |
| $2.5M |
| 100% |
| Filing → |
| ACN | SELL | 2025-05-14 | $813K | — | Filing → |
| ACN | SELL | 2025-01-27 | $1.8M | — | Filing → |
| ACN | SELL | 2024-10-18 | $3.6M | — | Filing → |